Back

Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis treated with transcatheter valve replacement: insights from the BEAT international collaborative registry

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Optimizing Risk Stratification and Technical Aspects of TAVI Procedures Aortic Valve Intervention ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Alfonso Ielasi

Clinical Institute Saint Ambrogio, Milan (Italy)

8 More presentations in this session

Presentation thumbnail
The adverse impact of HFpEF in patients with aortic stenosis: Evaluation of the H2FPEF score for risk assessment among patients with preserved ejection fraction undergoing TAVI
Mr S. Ludwig (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Incremental prognostic value of tricuspid annular dilatation over the STS score
Doctor S. Deseive (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Predictors of haemodynamic performance in patients with aortic stenosis and small annulus undergoing TAVI with self-expandable valves
Doctor M. Chiarito (Rozzano, IT)
Abstract Slides Video
Presentation thumbnail
A novel pressure-regulated deployment strategy for improving the safety and efficacy of balloon-expandable transcatheter aortic valves
Doctor A. Snir (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Impact of the timing of coronary revascularization relative to the transcatheter aortic valve implantation procedure: insights from a propensity score analysis based on a nationwide analysis
Professor P. Lantelme (Lyon, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Optimizing Risk Stratification and Technical Aspects of TAVI Procedures

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Aortic regurgitation and stenosis: diagnosis and mode of intervention
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Session
Controversies in heart valve disease: integrating art, science, medicine, and surgery into decision-making

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources